Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Gains from Sales and Divestitures: 2018-2020

Historic Gains from Sales and Divestitures for vTv Therapeutics (VTVT) over the last 2 years, with Dec 2020 value amounting to $11,667.

  • vTv Therapeutics' Gains from Sales and Divestitures was N/A to $11,667 in Q4 2020 from the same period last year, while for Dec 2020 it was $11,667, marking a year-over-year change of. This contributed to the annual value of $11,667 for FY2020, which is N/A change from last year.
  • Latest data reveals that vTv Therapeutics reported Gains from Sales and Divestitures of $11,667 as of FY2020, which was down 0.00% from $11,667 recorded in FY2018.
  • vTv Therapeutics' 5-year Gains from Sales and Divestitures high stood at $11,667 for FY2018, and its period low was $11,667 during FY2018.
  • Over the past 2 years, vTv Therapeutics' median Gains from Sales and Divestitures value was $11,667 (recorded in 2020), while the average stood at $11,667.